XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 1 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,799 | -28.1% | 10,616 | 0.0% | 0.00% | – |
Q2 2023 | $27,549 | +60.2% | 10,616 | 0.0% | 0.00% | – |
Q1 2023 | $17,198 | +27.6% | 10,616 | 0.0% | 0.00% | – |
Q4 2022 | $13,480 | -20.7% | 10,616 | 0.0% | 0.00% | – |
Q3 2022 | $17,000 | +6.2% | 10,616 | 0.0% | 0.00% | – |
Q2 2022 | $16,000 | -52.9% | 10,616 | -18.9% | 0.00% | – |
Q1 2022 | $34,000 | -19.0% | 13,090 | -9.0% | 0.00% | – |
Q4 2021 | $42,000 | – | 14,392 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 6,039,028 | $9,421,000 | 17.72% |
Stonepine Capital Management, LLC | 12,928,168 | $20,168,000 | 9.07% |
SINECERA CAPITAL, LLC | 253,101 | $395,000 | 0.46% |
NEA Management Company, LLC | 3,246,785 | $5,065,000 | 0.25% |
DELTEC ASSET MANAGEMENT LLC | 537,926 | $839,000 | 0.21% |
Kamunting Street Capital Management, L.P. | 75,000 | $117,000 | 0.19% |
Alpine Global Management, LLC | 400,000 | $624,000 | 0.15% |
ARMISTICE CAPITAL, LLC | 2,504,431 | $3,907,000 | 0.07% |
Redmile Group, LLC | 1,046,587 | $1,633,000 | 0.06% |
IHT Wealth Management, LLC | 335,287 | $523,000 | 0.04% |